|
SN-NJ-R184
N/A |
|
TPGS/PLGA nanoparticle composite hydrogel containing interference mitochondria
|
¥Member visible
|
|
SN-NJ-R185
N/A |
|
Lymphatic targeting siRNA carrier composite hydrogel
|
¥Member visible
|
|
SN-NJ-R186
N/A |
|
Targeted DNA liposome composite hydrogel
|
¥Member visible
|
|
SN-NJ-R187
N/A |
|
Peptide-mediated miRNA carrier composite hydrogel
|
¥Member visible
|
|
SN-NJ-R188
N/A |
|
RNA-loaded mimic liposome composite hydrogel
|
¥Member visible
|
|
SN-NJ-R189
N/A |
|
SpCas9 gene-edited liposome composite hydrogel
|
¥Member visible
|
|
SN-NJ-R190
N/A |
|
MiRNA liposome composite hydrogel for eyes
|
¥Member visible
|
|
SN-NJ-R191
N/A |
|
SiRNA liposome composite hydrogel for eyes
|
¥Member visible
|
|
SN-NJ-R192
N/A |
|
RNA mimic liposome composite hydrogel for eyes
|
¥Member visible
|
|
SN-NJ-R193
N/A |
|
Lymphatic targeting siRNA vesicle composite hydrogel
|
¥Member visible
|
|
SN-NJ-R194
N/A |
|
SpCas9 gene-edited hydrogel
|
¥Member visible
|
|
SN-NJ-R195
N/A |
|
Cationic nanoparticle composite hydrogel
|
¥Member visible
|
|
SN-NJ-R196
N/A |
|
Gene editing functional vector immune hydrogel
|
¥Member visible
|
|
SN-NJ-R197
N/A |
|
SiRNA-carrying chitosan carrier composite hydrogel
|
¥Member visible
|
|
SN-NJ-R198
N/A |
|
Cisplatin and siRNA liposome composite hydrogel
|
¥Member visible
|
|
SN-NJ-R199
N/A |
|
Fluorouracil-loaded siRNA liposome composite hydrogel
|
¥Member visible
|
|
SN-NJ-R201
N/A |
|
30℃ temperature sensitive hydrogel
|
¥Member visible
|
|
SN-NJ-R202
N/A |
|
Local long-acting sustained-release vaccine hydrogel
|
¥Member visible
|
|
SN-NJ-R203
N/A |
|
Chitosan Hydrogel
|
¥Member visible
|
|
SN-NJ-R204
N/A |
|
VEGF factor hydrogel
|
¥Member visible
|
|
SN-NJ-R205
N/A |
|
Injectable functional controlled release hydrogel
|
¥Member visible
|
|
SN-NJ-R206
N/A |
|
Injectable bionic hydrogel for bone mesenchymal stem cell therapy
|
¥Member visible
|
|
SN-NJ-R207
N/A |
|
Meniscus exfoliated cell matrix (ECM) bionic hydrogel
|
¥Member visible
|
|
SN-NP-H22
N/A |
|
Dex-SS-NH2 disulfide bond nanovesicles
|
¥Member visible
|
|
SN-NP-H32
N/A |
|
Enzyme response to paclitaxel vesicles
|
¥Member visible
|
|
SN-NP-I40
N/A |
|
PEG-PPS-PI ROS-responsive nanovesicles
|
¥Member visible
|
|
SN-NP-H11
N/A |
|
HER2 targeting nanovesicles
|
¥Member visible
|
|
SN-NP-H12
N/A |
|
Aminated nanovesicles
|
¥Member visible
|
|
SN-NP-H19
N/A |
|
Carboxylated nanovesicles
|
¥Member visible
|
|
SN-NP-H20
N/A |
|
Biotinylated nanovesicles
|
¥Member visible
|
|
SN-NP-H21
N/A |
|
Thiolated nanovesicles
|
¥Member visible
|
|
SN-NP-H23
N/A |
|
Folic acid targeting nucleic acid-loaded nanovesicles
|
¥Member visible
|